<table border="0" cellpadding="0" cellspacing="0" id="i5db51eac-fef4-404e-8784-406e119523eb" width="646" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>
                Table 6: Results of Drug Interaction Studies with Stavudine: Effects of
                Stavudine on Coadministered Drug Plasma AUC and C<sub>max</sub>
                Values
              </caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th>Drug</th>
<th> StavudineDosage  </th>
<th>
                    n<sup>a   </sup>
</th>
<th>
                    AUC of<br/> Coadministered 
                    <br/> Drug<br/>(95% CI)
                  </th>
<th>
                    C<sub>max</sub>
                    of<br/> Coadministered  <br/> Drug<br/>(95% CI)
                  </th>
</tr>
</thead>
<tbody>
<tr>
<td>
                    ↔ indicates no change, or mean increase or decrease of greater then 10%.<br/>
<sup>a</sup> HIV-infected
                    patients.<br/>
</td>
</tr>
</tbody>
<tbody>
<tr>
<td>
                    Didanosine, 100 mg<br/> q12h for 4 days<br/>
</td>
<td>
                    40 mg q12h<br/>for 4 days<br/>
</td>
<td>
                    10   <br/>
</td>
<td>
                    ↔<br/>
</td>
<td>
                    ↔<br/>
</td>
</tr>
<tr>
<td>
                    Lamivudine, 150 mg  <br/> single dose<br/>
</td>
<td>
                    40 mg single<br/>dose<br/>
</td>
<td>
                    18     <br/>
</td>
<td>
                    ↔<br/>(90.5-107.6%)<br/>
</td>
<td>
                    ↔ <br/>(87.1-110.6%)<br/>
</td>
</tr>
<tr>
<td>
                    Nelfinavir, 750 mg<br/> q8h for 56 days<br/>
</td>
<td>
                    30 to 40 mg q12h<br/>for 56 days<br/>
</td>
<td>
                    8   <br/>
</td>
<td>
                    ↔<br/>
</td>
<td>
                    ↔<br/>
</td>
</tr>
</tbody>
</table>